First-Line Seizure Medications Work Similarly for Children
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers conducted a study to examine the experiences and outcomes of pregnant individuals with epilepsy.
Researchers conducted a study to understand how the antiepileptic drug phenytoin affects driving performance and cognitive abilities.
Researchers investigated the effects of using preventive anticonvulsant medications in patients who experienced cardiac arrest and were treated with mild hypothermia.
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.
Researchers conducted a study to compare the effectiveness and safety of two medications, levetiracetam and sodium valproate, in treating children aged 1 to 16 years who were experiencing refractory generalized convulsive status epilepticus.
Researchers at Yangon Children’s Hospital studied the effectiveness of two medications, levetiracetam and phenobarbital, for treating prolonged seizures in children who did not respond to benzodiazepines.
Researchers studied a case involving a patient with epilepsy who developed obsessive-compulsive disorder (OCD) after starting treatment with a medication called levetiracetam.
Researchers conducted a study to analyze trends in pediatric epilepsy treatment research from 2005 to 2025.